Zenas BioPharma, Inc. (ZBIO)
43.17
+0.36
(+0.84%)
USD |
NASDAQ |
Dec 24, 16:00
Zenas BioPharma EPS Diluted (Quarterly): -1.222 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Royalty Pharma Plc | 0.6654 |
| Nektar Therapeutics | -1.875 |
| Rigel Pharmaceuticals, Inc. | 1.456 |
| XOMA Royalty Corp. | 0.6991 |
| Viridian Therapeutics, Inc. | -0.423 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -51.50M |
| Total Expenses (Quarterly) | 51.50M |
| Enterprise Value | 1.516B |
| Earnings Yield | -10.50% |
| Normalized Earnings Yield | -10.30 |